NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Platform GPL34764 Query DataSets for GPL34764
Status Public on Jul 31, 2024
Title NS_Hs_NeuroPath_v1.0+PLS
Technology type other
Distribution custom-commercial
Organism Homo sapiens
Manufacturer Nanostring
Manufacture protocol nCounter Analysis System/ nSolver and Rosalind Platforms were used as indicated by the manufacturer.
 
 
Submission date Jul 31, 2024
Last update date Aug 01, 2024
Contact name Maria Cecilia Marcondes
E-mail(s) cmarcondes@SDBRI.org
Phone 858-200-7197
Organization name San Diego Biomedical Research Institute
Street address 3525 John Hopkins Ct. #200
City San Diego
State/province CA
ZIP/Postal code 92121
Country USA
 
Samples (99) GSM8434091, GSM8434092, GSM8434093, GSM8434094, GSM8434095, GSM8434096 
Series (1)
GSE273630 Dopamine-regulated biomarkers in peripheral blood of HIV+ Methamphetamine users

Data table header descriptions
ID
ProbeID Nucleotide sequence number used to develop the probe.
Codeset.Name Proprietary experiment code
ORF
Analyte.Type analyzed material (mRNA)
Is.Control 0
Probe.Annotation Biological process/pathway annotated
KEGG.Pathways Pathway annotation
Cell.Type Cell type annotated
Official.Gene.Name Gene name

Data table
ID ProbeID Codeset.Name ORF Analyte.Type Is.Control Probe.Annotation KEGG.Pathways Cell.Type Official.Gene.Name
ABAT NM_020686.5:268 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ABAT mRNA 0 Neuronal System hsa00250;hsa04727 ABAT
ABL1 NM_005157.3:3200 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ABL1 mRNA 0 Nervous system development;Signaling by Rho GTPases;DNA Repair;Cell Cycle;Transcriptional regulation by RUNX1;Infectious disease;Hemostasis hsa04012;hsa04014;hsa04110;hsa04360;hsa04722;hsa05130;hsa05131;hsa05200;hsa05206;hsa05220;hsa05416 ABL1
ACAA1 NM_001130410.1:1090 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ACAA1 mRNA 0 Metabolism of lipids;Neutrophil degranulation hsa00592;hsa04146 ACAA1
ACHE NM_000665.3:1057 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ACHE mRNA 0 Neuronal System;Metabolism of lipids;Peptide hormone metabolism hsa00564;hsa04725 ACHE
ACIN1 NM_001164815.1:3094 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ACIN1 mRNA 0 Apoptosis hsa03013;hsa03040 ACIN1
ACTN1 NM_001102.3:2760 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ACTN1 mRNA 0 Hemostasis;Extracellular matrix organization;Cell-Cell communication hsa04510;hsa04520;hsa04530;hsa04670;hsa04810;hsa05146;hsa05203;hsa05322;hsa05412 ACTN1
ACVRL1 NM_000020.1:1710 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ACVRL1 mRNA 0 Signaling by TGFB family members ACVRL1
ADAM10 NM_001110.2:1930 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADAM10 mRNA 0 Nervous system development;Extracellular matrix organization;Diseases of signal transduction by growth factor receptors and second messengers;Neutrophil degranulation;Post-translational protein modification;Amyloid fiber formation hsa05010;hsa05120 ADAM10
ADCY5 NM_183357.2:2350 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADCY5 mRNA 0 Neuronal System;Intracellular signaling by second messengers;G alpha (i) signalling events;Transport of small molecules;Infectious disease hsa00230;hsa04015;hsa04022;hsa04024;hsa04062;hsa04072;hsa04114;hsa04211;hsa04213;hsa04261;hsa04270;hsa04540;hsa04611;hsa04713;hsa04723;hsa04724;hsa04725;hsa04726;hsa04727;hsa04728;hsa04750;hsa04911;hsa04912;hsa04913;hsa04914;hsa04915;hsa04916;hsa04918;hsa04921;hsa04923;hsa04924;hsa04925;hsa04970;hsa04971;hsa04972;hsa04976;hsa05012;hsa05030;hsa05031;hsa05032;hsa05034;hsa05166;hsa05200;hsa05414 ADCY5
ADCY8 NM_001115.2:2260 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADCY8 mRNA 0 Neuronal System;Intracellular signaling by second messengers;G alpha (i) signalling events;Transport of small molecules;Infectious disease hsa00230;hsa04015;hsa04020;hsa04022;hsa04024;hsa04062;hsa04072;hsa04114;hsa04211;hsa04213;hsa04261;hsa04270;hsa04540;hsa04611;hsa04713;hsa04720;hsa04723;hsa04724;hsa04725;hsa04727;hsa04742;hsa04750;hsa04911;hsa04912;hsa04913;hsa04914;hsa04915;hsa04916;hsa04918;hsa04921;hsa04923;hsa04925;hsa04970;hsa04971;hsa04972;hsa04976;hsa05032;hsa05166;hsa05200;hsa05414 ADCY8
ADCY9 NM_001116.3:6400 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADCY9 mRNA 0 Neuronal System;Intracellular signaling by second messengers;G alpha (i) signalling events;Transport of small molecules;Infectious disease hsa00230;hsa04015;hsa04020;hsa04022;hsa04024;hsa04062;hsa04072;hsa04114;hsa04211;hsa04213;hsa04261;hsa04270;hsa04540;hsa04611;hsa04713;hsa04723;hsa04724;hsa04725;hsa04727;hsa04750;hsa04911;hsa04912;hsa04913;hsa04914;hsa04915;hsa04916;hsa04918;hsa04921;hsa04923;hsa04925;hsa04961;hsa04962;hsa04970;hsa04971;hsa04972;hsa04976;hsa05032;hsa05110;hsa05166;hsa05200;hsa05414 ADCY9
ADCYAP1 NM_001117.4:1725 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADCYAP1 mRNA 0 GPCR ligand binding;Signaling by NTRKs;Infectious disease hsa04911;hsa04924 ADCYAP1
ADORA1 NM_000674.1:1150 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADORA1 mRNA 0 GPCR ligand binding;G alpha (i) signalling events hsa04022;hsa04024;hsa04071;hsa04080;hsa04923;hsa04924;hsa05032 ADORA1
ADORA2A NM_000675.3:1095 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADORA2A mRNA 0 GPCR ligand binding;Signaling by NTRKs;Infectious disease hsa04015;hsa04020;hsa04024;hsa04080;hsa04270;hsa05012;hsa05034 ADORA2A
ADRA2A NM_000681.2:2490 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADRA2A mRNA 0 Hemostasis;GPCR ligand binding;G alpha (i) signalling events hsa04022;hsa04080 ADRA2A
ADRB2 NM_000024.3:1245 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 ADRB2 mRNA 0 Post-translational protein modification;GPCR ligand binding;Vesicle-mediated transport;Infectious disease hsa04020;hsa04022;hsa04024;hsa04080;hsa04144;hsa04261;hsa04923;hsa04924;hsa04970 ADRB2
AGER NM_001136.3:340 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 AGER mRNA 0 Signaling by Interleukins hsa04933 AGER
AIF1 NM_032955.1:185 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 AIF1 mRNA 0 AIF1
AKT1 NM_001014432.1:1275 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 AKT1 mRNA 0 Hemostasis;Apoptosis;Intracellular signaling by second messengers;Vesicle-mediated transport;Metabolism of vitamins and cofactors;Metabolism of nitric oxide: NOS3 activation and regulation;Signaling by WNT;Adaptive Immune System;Metabolism of RNA;Signaling by VEGF;Diseases of signal transduction by growth factor receptors and second messengers;Signaling by Interleukins;Cell Cycle;Signaling by PTK6;Signaling by Nuclear Receptors hsa04010;hsa04012;hsa04014;hsa04015;hsa04022;hsa04024;hsa04062;hsa04066;hsa04068;hsa04071;hsa04072;hsa04150;hsa04151;hsa04152;hsa04210;hsa04211;hsa04213;hsa04261;hsa04370;hsa04380;hsa04510;hsa04530;hsa04550;hsa04611;hsa04620;hsa04630;hsa04660;hsa04662;hsa04664;hsa04666;hsa04668;hsa04722;hsa04725;hsa04728;hsa04910;hsa04914;hsa04915;hsa04917;hsa04919;hsa04920;hsa04922;hsa04923;hsa04931;hsa04932;hsa04933;hsa04973;hsa05142;hsa05145;hsa05152;hsa05160;hsa05161;hsa05162;hsa05164;hsa05166;hsa05169;hsa05200;hsa05205;hsa05210;hsa05211;hsa05212;hsa05213;hsa05214;hsa05215;hsa05218;hsa05220;hsa05221;hsa05222;hsa05223;hsa05230;hsa05231 AKT1
AKT1S1 NM_032375.3:1850 NS_HS_NEUROPATH_V1.0+PLS_MARCONDES_1_C7715 AKT1S1 mRNA 0 Cellular responses to external stimuli;Intracellular signaling by second messengers;Diseases of signal transduction by growth factor receptors and second messengers hsa04150;hsa04152;hsa04211;hsa04213 AKT1S1

Total number of rows: 780

Table truncated, full table size 165 Kbytes.




Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp

Supplementary data files not provided
| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap